3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
34
Terminated
8
Unknown
3
Active not recruiting
2
Withdrawn
1
No longer available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
11
Myeloid
8
Lymphoid
8
Plasma cell
2
Classical hematology
2
CNS
2
Thoracic
1
Sarcoma
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Sarcoma, Ewing
1
Interventions
Cyclophosphamide
9
Radiotherapy
8
Temozolomide
6
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Doxorubicin
6
pazopanib
5
Gemcitabine
5
pembrolizumab
4
Vincristine
4
Radiation
4
Etoposide
4
Docetaxel
4
Carboplatin
4
Biopsy
4
Trabectedin
3
Taxes
3
Specimen Handling
3
Paclitaxel
3
Nivolumab
3
Irinotecan
3
Drug Therapy
3
olaparib
2
niraparib
2
liposomal doxorubicin
2
fludarabine phosphate
2
fludarabine
2
brigimadlin
2
Trastuzumab
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Busulfan
×
Sarcoma
×
Clear all
NCT01969942
2017-05-09
ASCT
University of Louisville
Phase 1
Withdrawn